Insider · CIK 0001866174

WALSH COLIN

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001866174

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-08-06	ATTOAttovia Therapeutics, Inc.C Conversion	Director	CConversion	+1.96M sh	—	—	2,042,134
2026-08-06	ATTOAttovia Therapeutics, Inc.C Conversion	Director	CConversion	+478K sh	—	—	2,520,632
2026-08-06	ATTOAttovia Therapeutics, Inc.P Purchase	Director	PPurchase	+500K sh	$17.00	+$8.5M	3,020,632
2026-08-06	ATTOAttovia Therapeutics, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−18.2M sh	—	—	0
2026-08-06	ATTOAttovia Therapeutics, Inc. · Series C Preferred StockC Conversion	Director	CConversion	−4.45M sh	—	—	0
2026-08-06	ATTOAttovia Therapeutics, Inc.C Conversion	Director	CConversion	+1.96M sh	—	—	2,042,134
2026-08-06	ATTOAttovia Therapeutics, Inc.C Conversion	Director	CConversion	+478K sh	—	—	2,520,632
2026-08-06	ATTOAttovia Therapeutics, Inc.P Purchase	Director	PPurchase	+500K sh	$17.00	+$8.5M	3,020,632
2026-08-06	ATTOAttovia Therapeutics, Inc. · Series B Preferred StockC Conversion	Director	CConversion	−18.2M sh	—	—	0
2026-08-06	ATTOAttovia Therapeutics, Inc. · Series C Preferred StockC Conversion	Director	CConversion	−4.45M sh	—	—	0
2026-08-05	ATTOAttovia Therapeutics, Inc.P Purchase	Director	PPurchase	+85K sh	$21.00	+$1.79M	85,000
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−988 sh	$22.03	−$21.8K	84,012
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−447 sh	$21.87	−$9,775.89	83,565
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−1,332 sh	$22.03	−$29.3K	82,233
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−200 sh	$22.05	−$4,410	82,033
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−1,556 sh	$22.06	−$34.3K	80,477
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−3,402 sh	$22.02	−$74.9K	77,075
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−200 sh	$22.10	−$4,420	76,875
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−480 sh	$21.55	−$10.3K	76,395
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−100 sh	$22.11	−$2,211	76,295
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−753 sh	$21.97	−$16.5K	75,542
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−672 sh	$22.02	−$14.8K	74,870
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−6,970 sh	$22.03	−$154K	67,900
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−400 sh	$22.02	−$8,808	67,500
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−1,180 sh	$21.84	−$25.8K	66,320
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−1,040 sh	$22.05	−$22.9K	65,280
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−300 sh	$20.84	−$6,252	64,980
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−443 sh	$21.78	−$9,648.54	64,537
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−200 sh	$22.05	−$4,410	64,337
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−700 sh	$22.07	−$15.4K	63,637
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−1,163 sh	$22.19	−$25.8K	62,474
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−100 sh	$21.99	−$2,199	62,374
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−6,763 sh	$21.61	−$146K	55,611
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−76.4K sh	$21.04	−$1.61M	0
2026-08-05	ATTOAttovia Therapeutics, Inc.P Purchase	Director	PPurchase	+85K sh	$21.00	+$1.79M	85,000
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−988 sh	$22.03	−$21.8K	84,012
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−447 sh	$21.87	−$9,775.89	83,565
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−1,332 sh	$22.03	−$29.3K	82,233
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−200 sh	$22.05	−$4,410	82,033
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−1,556 sh	$22.06	−$34.3K	80,477
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−3,402 sh	$22.02	−$74.9K	77,075
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−200 sh	$22.10	−$4,420	76,875
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−480 sh	$21.55	−$10.3K	76,395
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−100 sh	$22.11	−$2,211	76,295
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−753 sh	$21.97	−$16.5K	75,542
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−672 sh	$22.02	−$14.8K	74,870
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−6,970 sh	$22.03	−$154K	67,900
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−400 sh	$22.02	−$8,808	67,500
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−1,180 sh	$21.84	−$25.8K	66,320
2026-08-05	ATTOAttovia Therapeutics, Inc.S Sale	Director	SSale	−1,040 sh	$22.05	−$22.9K	65,280

Recent filings

Accepted (ET)
Aug 284/A
WALSH COLIN0001866174-26-000011
SEC(opens sec.gov)

Companies

Address

C/O GOLDMAN SACHS GROUP INC. 2OO WEST STREET

NEW YORK, NY, 10282